Improvement of Hailey–Hailey disease with abrocitinib
Yufen Li, Yiqun Jiang, Jianfang Sun
Abstract
We describe a patient with classical Hailey–Hailey disease who was successfully treated with the Janus kinase (JAK)1 inhibitor abrocitinib. To our knowledge, abrocitinib has not previously been described in the medical literature as a treatment option for HHD.
Topics & Concepts
Hailey–Hailey diseaseDermatologyMedicineJanus kinaseDiseasePemphigusInternal medicineCytokineGenetic and rare skin diseases.Hedgehog Signaling Pathway StudiesCancer and Skin Lesions